Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0HH0U
|
|||
| Former ID |
DIB010975
|
|||
| Drug Name |
S-488410
|
|||
| Synonyms |
S-488401; S-488402; Peptide vaccine (lung/ esophagael cancer), OncoTherapy Science; Peptide vaccine (lung/ esophagael cancer), Shionogi
Click to Show/Hide
|
|||
| Indication | Lung cancer [ICD-11: 2C25.0; ICD-9: 162] | Phase 2 | [1] | |
| Company |
OncoTherapy Science Inc
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01592617) Phase II Study of S-488410 to Treat Non-small Cell Lung Cancer. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.